{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT02482129: Phase 2 Interventional Completed Acute Anterior Uveitis
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:retatrutide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:oberotatug ravtansine [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:itanistomig [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:stapokibart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:narlumosbart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01471990: Not Applicable Interventional Completed Migraine Without Aura
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tilogotamab [INN]
Source URL:
Class:
PROTEIN
